GR1001131B - Χαμηλης δοσης συνθεση απο του στοματος χορηγουμενου αντιθρομβωτικου / αναστολεα της δρασης των αιμοπεταλιων - Google Patents

Χαμηλης δοσης συνθεση απο του στοματος χορηγουμενου αντιθρομβωτικου / αναστολεα της δρασης των αιμοπεταλιων

Info

Publication number
GR1001131B
GR1001131B GR900100702A GR900100702A GR1001131B GR 1001131 B GR1001131 B GR 1001131B GR 900100702 A GR900100702 A GR 900100702A GR 900100702 A GR900100702 A GR 900100702A GR 1001131 B GR1001131 B GR 1001131B
Authority
GR
Greece
Prior art keywords
low dosage
antithrombotic composition
dosage oral
oral antithrombotic
combination products
Prior art date
Application number
GR900100702A
Other languages
English (en)
Other versions
GR900100702A (en
Inventor
Joseph William Addicks
A Joseph Mollica
Howard Gary Slatko
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of GR900100702A publication Critical patent/GR900100702A/el
Publication of GR1001131B publication Critical patent/GR1001131B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

Εδώ περιγράφονται προϊόντα συνδυασμού ωφέλιμα για την αγωγή ή/και την προφύλαξη από ένα πρώτο ή υποτροπιάζων έμφραγμα του μυοκαρδίου ή μια πρώτη ή υποτροπιάζουσα συμφόρηση. Τα αναφερ?έντα προϊόντα συνδυασμού περιλαμβάνουν μικρές δόσεις ενός στοματικού αντι?ρομβωτικού κατά προτίμηση της γουαρφαρίνης και παραγόντων αναστολής της συσσωμάτωσης των αιμοπεταλίων περιλαμβανόντων μηστεροειδείς αντιφλεγμονώδεις παράγοντες και κατά προτίμηση ασπιρίνη. ω
GR900100702A 1989-09-18 1990-09-18 Χαμηλης δοσης συνθεση απο του στοματος χορηγουμενου αντιθρομβωτικου / αναστολεα της δρασης των αιμοπεταλιων GR1001131B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/408,394 US5041430A (en) 1989-09-18 1989-09-18 Oral anticoagulant/platelet inhibitor low dose formulation

Publications (2)

Publication Number Publication Date
GR900100702A GR900100702A (en) 1992-01-20
GR1001131B true GR1001131B (el) 1993-04-28

Family

ID=23616120

Family Applications (1)

Application Number Title Priority Date Filing Date
GR900100702A GR1001131B (el) 1989-09-18 1990-09-18 Χαμηλης δοσης συνθεση απο του στοματος χορηγουμενου αντιθρομβωτικου / αναστολεα της δρασης των αιμοπεταλιων

Country Status (22)

Country Link
US (1) US5041430A (el)
EP (1) EP0493408B1 (el)
JP (1) JPH05501109A (el)
KR (1) KR950008307B1 (el)
AT (1) ATE137972T1 (el)
AU (1) AU635881B2 (el)
CA (1) CA2065347A1 (el)
CZ (1) CZ454090A3 (el)
DE (1) DE69027036D1 (el)
FI (1) FI921134A (el)
GR (1) GR1001131B (el)
HU (1) HUT62488A (el)
IE (1) IE903356A1 (el)
IL (1) IL95721A (el)
LV (1) LV10050B (el)
MA (1) MA21953A1 (el)
MX (1) MX173727B (el)
NO (1) NO920946L (el)
NZ (1) NZ235337A (el)
PT (1) PT95343B (el)
WO (1) WO1991004031A1 (el)
ZA (1) ZA907431B (el)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672585A (en) * 1990-04-06 1997-09-30 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5612311A (en) 1990-04-06 1997-03-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US6521594B1 (en) 1990-04-06 2003-02-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5635477A (en) * 1991-09-30 1997-06-03 The Dupont Merck Pharmaceutical Company Cyclic compounds useful as inhibitors of platelet glycoprotein IIB/IIIA
CA2100836C (en) * 1993-07-19 1998-02-03 Bernard Charles Sherman PHARMACEUTICAL COMPOSITION
EP0821587A4 (en) * 1995-04-19 1999-05-19 Lipoprotein Technologies Inc COMPOSITIONS, KITS AND METHODS FOR ADMINISTERING ANTILIPEMICS AND MEDICINES AGAINST PLATELET AGGREGATION
US8022095B2 (en) * 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US6121249A (en) * 1998-07-01 2000-09-19 Donald L. Weissman Treatment and prevention of cardiovascular diseases with help of aspirin, antioxidants, niacin, and certain B vitamins
IT1312088B1 (it) * 1999-04-21 2002-04-04 Altergon Sa Cerotto per uso topico contenente eparina e diclofenac.
US8173164B2 (en) * 1999-06-17 2012-05-08 Gruenenthal Gmbh Oral administration forms for administering a fixed tramadol and diclofenac combination
WO2002043806A2 (en) * 2000-12-01 2002-06-06 Rheologics, Inc In vivo delivery methods and compositions
WO2002079778A2 (en) * 2001-03-28 2002-10-10 Rheologics, Inc. In vivo delivery methods and compositions
US7691833B2 (en) * 2002-03-01 2010-04-06 Trustees Of Dartmouth College Compositions and methods for preventing sporadic neoplasia in colon
CA2512666A1 (en) * 2003-01-08 2004-07-29 Flacco-Nesselroad Family Trust Combination therapy for anticoagulation
CZ20032854A3 (cs) * 2003-10-17 2005-05-18 Pliva - Lachema A.S. Způsob přípravy dávkových jednotek pevné lékové formy obsahujících jako účinnou látku sodnou sůl warfarinu
CA2553156A1 (en) * 2003-10-20 2005-05-12 Teva Pharmaceutical Industries Ltd. Composition and dosage form for sustained effect of levodopa
SI21637A (sl) * 2003-12-23 2005-06-30 LEK farmacevtska dru�ba d.d. Farmacevtska oblika z nadzorovanim sproščanjem
US20060003000A1 (en) * 2004-07-01 2006-01-05 Lawrence Solomon Adhesively bonded dosage form
US7838031B2 (en) * 2004-05-21 2010-11-23 Lawrence Solomon Method of administering a partial dose using a segmented pharmaceutical tablet
WO2005112898A1 (en) * 2004-05-21 2005-12-01 Accu-Break Pharmaceuticals, Inc. Pharmaceutical tablets having a relatively inactive segment
US8758814B2 (en) 2004-10-08 2014-06-24 Mcneil-Ppc, Inc. Chewable enteric coated aspirin tablets
US8057820B2 (en) * 2004-10-08 2011-11-15 Mcneil-Ppc, Inc. Enteric coated aspirin granules comingled with binder
JP4613590B2 (ja) 2004-11-16 2011-01-19 セイコーエプソン株式会社 実装基板及び電子機器
US20100034878A1 (en) * 2006-12-19 2010-02-11 Bussey Henry I Combination of vitamin k and vitamin k antagonist such as r-isomer of warfarin, phenprocoumon or r-isomer of phenprocoumon as anticoagulant therapy
WO2008156691A1 (en) * 2007-06-19 2008-12-24 Duke University Anitcoagulants as antifouling agents
DE102008014237A1 (de) * 2008-03-14 2009-09-17 J. Rettenmaier & Söhne Gmbh + Co. Kg Direktverpressbares Tablettierhilfsmittel
JP5529404B2 (ja) * 2008-09-05 2014-06-25 東和薬品株式会社 アスピリン腸溶錠
WO2012060847A1 (en) 2010-11-07 2012-05-10 Targegen, Inc. Compositions and methods for treating myelofibrosis
LV14606B (lv) 2011-05-17 2013-01-20 Tetra, Sia Jauns XII faktora inhibitors
CZ304136B6 (cs) * 2012-06-27 2013-11-13 Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta Zpusob prípravy pevné lékové formy se sodnou solí warfarinu ve forme klathrátu izopropanolu
JP6304751B2 (ja) * 2014-03-24 2018-04-04 日新製薬株式会社 ワルファリン含有固形製剤及びその製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2265273A1 (en) * 1974-03-29 1975-10-24 Zootherap Laboratoires Anticoagulant-contg. rodenticidal compsn. - contg. (acetyl) salicyclic acid or salt as synergist
LU77353A1 (el) * 1977-05-16 1979-01-19
GB2038625B (en) * 1978-12-29 1983-01-12 Parcor Therapeutic composition having an antithrombotic and antiblood-platelet-aggregating activity
EP0001503B1 (en) * 1977-10-08 1981-01-07 Beecham Group Plc Antithrombotic compositions containing benzisothiazolones
SU1050708A1 (ru) * 1981-04-27 1983-10-30 Горьковский государственный медицинский институт им.С.М.Кирова Способ лечени гиперкоагул ции при коронарном атеросклерозе
US4444777A (en) * 1981-07-30 1984-04-24 Bristol-Myers Company Pharmaceutical compositions of anagrelide and sulfinpyrazone
DE3576119D1 (de) * 1984-07-21 1990-04-05 Hoechst Ag Kombinationspraeparat aus pyrimido-pyrimidinen und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung.

Also Published As

Publication number Publication date
ZA907431B (en) 1992-05-27
LV10050B (en) 1995-02-20
PT95343B (pt) 1998-06-30
IL95721A0 (en) 1991-06-30
HUT62488A (en) 1993-05-28
ATE137972T1 (de) 1996-06-15
NO920946D0 (no) 1992-03-11
AU6330690A (en) 1991-04-18
GR900100702A (en) 1992-01-20
LV10050A (lv) 1994-05-10
KR920703046A (ko) 1992-12-17
FI921134A0 (fi) 1992-03-17
MA21953A1 (fr) 1991-04-01
WO1991004031A1 (en) 1991-04-04
CA2065347A1 (en) 1991-03-19
IL95721A (en) 1995-07-31
AU635881B2 (en) 1993-04-01
KR950008307B1 (ko) 1995-07-27
MX173727B (es) 1994-03-24
FI921134A (fi) 1992-03-17
DE69027036D1 (de) 1996-06-20
PT95343A (pt) 1991-08-14
NZ235337A (en) 1993-05-26
NO920946L (no) 1992-03-11
JPH05501109A (ja) 1993-03-04
IE903356A1 (en) 1991-04-10
EP0493408A1 (en) 1992-07-08
EP0493408A4 (en) 1992-10-07
US5041430A (en) 1991-08-20
CZ454090A3 (en) 1996-11-13
EP0493408B1 (en) 1996-05-15

Similar Documents

Publication Publication Date Title
GR900100702A (en) Low dosage oral antithrombotic composition
ES511433A0 (es) "procedimiento de preparacion de productos utiles particularmente en medicamentos utilizables para el tratamiento de melanomas".
ATE279922T1 (de) Behandlung von zns-wirkungen des hiv mit vx-478, allein oder kombiniert mit azt oder 3tc
FI922364A0 (fi) Farmaceutiska kompositioner.
FI893643A (fi) Farmaceutiska kompositioner.
DZ1618A1 (fr) Procédé de préparation de distilmats moyens.
IT8721687A0 (it) Derivati dell'ossima della 1,2,5,6-tetraidropiridin-3-carbossa ldeide, loro procedimento di preparazione e loro impiego come sostanze medicinali.
NO894158D0 (no) Curcumin ved paavisning av varsling av cyanid-oppblandete naeringsmidler.
IT1207996B (it) Composti contenenti ferro biodisponibile, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
FR2707455B1 (fr) Empêchement de la reproduction des insectes xylophages, moyens pour le traitement préventif du matériau bois mis en Óoeuvre.
IT8721540A0 (it) Composizioni farmaceutiche contenenti trapidil, loro procedimento di preparazione erelativo impiego terapeutico.
DE69003003D1 (de) Pharmazeutische Zusammensetzung.
AR240016A1 (es) Procedimiento de preparacion de una composicion para el tratamiento de flebectasias.
IT216152Z2 (it) Chiusura di stivale da motocross.
KR920700037A (ko) 치료에 유용한 혈소판 항-응집 효과를 갖는 조성물
ZA892724B (en) N-alkylamino derivatives of aromatic,tricyclic compounds in the treatment of drug-resistant protozoan infections
IT8820182A0 (it) Composti di ferro biodisponibile, loro preparazione e composizioni che li contengono.
ES1011155Y (es) Colgador de doble percha.
IT8522079A0 (it) Derivati dell'aspirina, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT8919204A0 (it) Composizione per la prevenzione e la cura di parodontopatte.
AR240472Q (es) Un procedimiento para la preparaciond e una composicon lubricante de derivados carboxilicos.
ATE72979T1 (de) Zusammenstellung zur behandlung der osteoporose beim menschen.
MX9203089A (es) Composicion para el tratamiento de esquisofrenia.
MX11486A (es) Procedimiento para la preparacion de una composicion farmaceutica y composicion obtenida.
IT8819258A0 (it) Composizioni iniettabili per il trattamento delle encefalopatie epatiche.